Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Jan 25, 2023 11:34am
114 Views
Post# 35245263

RE:RE:Voting Down The Midatech Deal

RE:RE:Voting Down The Midatech Deal
Without criticizing you, fuzzyjr, let me point out something...
 
I write in the following ways.
 
If this and this can happen then these other things can happen.
This technology, ______________, does not appear to compete with xB3 for the following reasons...
If Bioasis does that, then these may be the consequences...
If xB3 works as hoped, then it should be worth a lot of money. (Duh!)
Here's a scientific paper that sheds some light on ___________. I think it's interesting that....
Here's a question I think shareholders should be asking....
 
That's how I write, fuzzy. I've always tried to give the best commentary I could whether it damaged my standing with shareholders or management.
 
I've certainly taken a lot of heat from both over my writings.
 
Your shot at me, fuzzy, was uncalled for.
 
So, now, uncle and the others will step in and the day will be lost because I responded to your unsupportable personal shot at me. I don't initiate attacks but I do respond to them all. That will not change.

Your call, fuzzyjr.
 
jd
<< Previous
Bullboard Posts
Next >>